Fennec amends loan agreement with Bridge Bank; sets PEDMARK NDA resubmission and approval milestones

FENNEC PHARMACEUTICALS INC.

Third Amendment to 2019 Loan & Security Agreement with Bridge Bank (Western Alliance Bank) dated Jan 27, 2022.
Defines 'Resubmission Event': resubmission of PEDMARK NDA to FDA on or before March 31, 2022.
Defines 'Approval Event': receipt of final NDA approval for PEDMARK on or before September 30, 2022.
Second Draw Period commences upon Approval Event; proceeds for commercial readiness prior to potential PEDMARK approval.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.